2024 Q2 Form 10-K Financial Statement
#000149315224019773 Filed on May 15, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 | 2024 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $975.0K | $1.768M | $3.005M |
YoY Change | 143.04% | -57.43% | -27.65% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $975.0K | $1.768M | $3.005M |
YoY Change | 143.04% | -57.43% | -27.65% |
Operating Profit | -$975.0K | -$3.005M | |
YoY Change | 143.04% | -27.65% | |
Interest Expense | $49.81K | -$121.3K | $401.0K |
YoY Change | -53.52% | -64.42% | -217.62% |
% of Operating Profit | |||
Other Income/Expense, Net | -$69.30K | -$79.88K | -$707.4K |
YoY Change | -60.13% | 1209.51% | 11496.11% |
Pretax Income | -$1.044M | -$1.969M | -$3.712M |
YoY Change | 81.61% | -54.2% | -13.66% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$1.044M | -$1.969M | -$3.712M |
YoY Change | 81.61% | -54.2% | -13.66% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | -$0.02 | |
Diluted Earnings Per Share | $0.00 | -$0.01 | -$0.02 |
COMMON SHARES | |||
Basic Shares Outstanding | 248.2M shares | 211.3M shares | |
Diluted Shares Outstanding | 224.3M shares | 211.3M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 | 2024 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.005M | $30.15K | $30.15K |
YoY Change | 761.04% | -93.01% | -93.01% |
Cash & Equivalents | $1.005M | $30.15K | |
Short-Term Investments | |||
Other Short-Term Assets | $103.8K | $21.62K | $21.62K |
YoY Change | 338.26% | ||
Inventory | |||
Prepaid Expenses | $103.8K | $21.62K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $1.109M | $51.77K | $51.77K |
YoY Change | 689.76% | -88.0% | -88.0% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $40.45K | ||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $100.0K | $100.0K | $100.0K |
YoY Change | 0.0% | 0.0% | 0.0% |
Total Long-Term Assets | $140.4K | $100.0K | $100.0K |
YoY Change | 40.45% | 0.0% | 0.0% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.109M | $51.77K | $51.77K |
Total Long-Term Assets | $140.4K | $100.0K | $100.0K |
Total Assets | $1.249M | $151.8K | $151.8K |
YoY Change | 419.66% | -71.44% | -71.44% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $406.0K | $434.5K | $434.5K |
YoY Change | 43.28% | 22.48% | 22.48% |
Accrued Expenses | $883.1K | $1.486M | $1.486M |
YoY Change | 433.25% | 1512.44% | 1512.44% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $260.0K | ||
YoY Change | |||
Total Short-Term Liabilities | $1.549M | $1.920M | $1.920M |
YoY Change | 245.04% | 329.7% | 329.7% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $2.875M | $3.759M | $3.759M |
YoY Change | -15.98% | 12.09% | 12.09% |
Other Long-Term Liabilities | $1.344M | $533.0K | $533.0K |
YoY Change | -5.64% | -60.57% | -60.57% |
Total Long-Term Liabilities | $4.219M | $4.292M | $4.292M |
YoY Change | -12.94% | -8.78% | -8.78% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.549M | $1.920M | $1.920M |
Total Long-Term Liabilities | $4.219M | $4.292M | $4.292M |
Total Liabilities | $5.768M | $6.212M | $6.212M |
YoY Change | 8.93% | 20.58% | 20.58% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$33.05M | -$31.60M | |
YoY Change | 16.11% | 13.31% | |
Common Stock | $247.0K | $214.6K | |
YoY Change | 18.0% | 2.97% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$4.519M | -$6.061M | -$6.061M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.249M | $151.8K | $151.8K |
YoY Change | 419.66% | -71.44% | -71.44% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 | 2024 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.044M | -$1.969M | -$3.712M |
YoY Change | 81.61% | -54.2% | -13.66% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$778.4K | -$253.6K | -$868.4K |
YoY Change | 147.4% | 71.83% | 488.49% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $1.753M | 266.0K | $467.2K |
YoY Change | -26.32% | 29.42% | |
NET CHANGE | |||
Cash From Operating Activities | -$778.4K | -253.6K | -$868.4K |
Cash From Investing Activities | |||
Cash From Financing Activities | $1.753M | 266.0K | $467.2K |
Net Change In Cash | $974.9K | 12.43K | -$401.2K |
YoY Change | -409.82% | -94.18% | -287.99% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$778.4K | -$253.6K | -$868.4K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2024 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001263364 | |
CY2023Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
usd | |
CY2023Q1 | us-gaap |
Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
|
usd | |
CY2023 | COPR |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
usd | |
CY2024 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
usd | |
CY2023 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
usd | |
CY2023 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
usd | |
CY2024 | COPR |
Convertible Notes Payable Issued For Expenses
ConvertibleNotesPayableIssuedForExpenses
|
usd | |
CY2024 | COPR |
Expenses Paid By Parent Company
ExpensesPaidByParentCompany
|
usd | |
CY2023 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
usd | |
CY2023 | us-gaap |
Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
|
usd | |
CY2024 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2024 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2024 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2023 | COPR |
Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
|
usd | |
CY2024 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
usd | |
CY2024Q1 | COPR |
Bond Liabilities Maturities In Next Twelve Months
BondLiabilitiesMaturitiesInNextTwelveMonths
|
usd | |
CY2024Q1 | COPR |
Bond Liabilities Maturities In Year Four
BondLiabilitiesMaturitiesInYearFour
|
usd | |
CY2024Q1 | COPR |
Bond Liabilities Maturities Thereafter
BondLiabilitiesMaturitiesThereafter
|
usd | |
CY2024 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2024Q1 | COPR |
Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
|
usd | |
CY2023Q1 | COPR |
Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
|
usd | |
CY2024Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023Q1 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2024 | dei |
Document Type
DocumentType
|
10-K | |
CY2024 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2024 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-01-31 | |
CY2024 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--01-31 | |
CY2024 | dei |
Entity File Number
EntityFileNumber
|
333-108715 | |
CY2024 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2024 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
Yes | |
CY2024 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2024 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2024 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q3 | dei |
Entity Public Float
EntityPublicFloat
|
13340657 | usd |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
248212528 | shares |
CY2024 | dei |
Auditor Firm
AuditorFirmId
|
6580 | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
76 | |
CY2024 | dei |
Auditor Name
AuditorName
|
GreenGrowth CPAs | |
CY2024 | dei |
Auditor Location
AuditorLocation
|
Los Angeles, California | |
CY2024 | dei |
Auditor Firm
AuditorFirmId
|
6580 | |
CY2023 | dei |
Auditor Name
AuditorName
|
Turner, Stone & Company, L.L.P. | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Dallas, Texas | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
30146 | usd |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
431374 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
21624 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
51770 | usd |
CY2023Q1 | us-gaap |
Assets Current
AssetsCurrent
|
431374 | usd |
CY2024Q1 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
100000 | usd |
CY2023Q1 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
100000 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
151770 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
531374 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
434519 | usd |
CY2023Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
354763 | usd |
CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
1115723 | usd |
CY2023Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
8817 | usd |
CY2023 | us-gaap |
Professional Fees
ProfessionalFees
|
240324 | usd |
CY2024 | COPR |
Payroll And Related Expenses
PayrollAndRelatedExpenses
|
318561 | usd |
CY2023 | COPR |
Payroll And Related Expenses
PayrollAndRelatedExpenses
|
963055 | usd |
CY2023 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
42000 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2769292 | usd |
CY2023 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
138214 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
4152885 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4152885 | usd |
CY2023 | COPR |
Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
|
6095 | usd |
CY2024 | COPR |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
45266 | usd |
CY2023 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
200458 | usd |
CY2024 | us-gaap |
Interest Expense
InterestExpense
|
401035 | usd |
CY2023 | us-gaap |
Interest Expense
InterestExpense
|
340948 | usd |
CY2024 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-707363 | usd |
CY2023 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-146585 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3712047 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4299470 | usd |
CY2023 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.18 | |
CY2023 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.18 | |
CY2023 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
24183399 | shares |
CY2023 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
24183399 | shares |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8294773 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
4519207 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
973293 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
1796000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
685166 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4299470 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4620577 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4620577 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4620577 | usd |
CY2024 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
309353 | usd |
CY2024 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
103846 | usd |
CY2024 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
269085 | usd |
CY2024 | COPR |
Stock Issued During Period Value Preferred Stock And Warrants
StockIssuedDuringPeriodValuePreferredStockAndWarrants
|
265000 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3712047 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6060609 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6060609 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3712047 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4299470 | usd |
CY2024 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2043909 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
2769292 | usd |
CY2024 | COPR |
Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
|
261062 | usd |
CY2023 | COPR |
Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
|
6095 | usd |
CY2024 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
45266 | usd |
CY2023 | COPR |
Convertible Notes Payable Issued For Expenses
ConvertibleNotesPayableIssuedForExpenses
|
360666 | usd |
CY2023 | COPR |
Expenses Paid By Parent Company
ExpensesPaidByParentCompany
|
395735 | usd |
CY2024 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
21624 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-5000 | usd |
CY2024 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
78757 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
281639 | usd |
CY2024 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
288689 | usd |
CY2023 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
83333 | usd |
CY2024 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-147560 | usd |
CY2023 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-250136 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-868428 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-147574 | usd |
CY2024 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
202200 | usd |
CY2024 | us-gaap |
Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
|
265000 | usd |
CY2023 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
361000 | usd |
CY2024 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
467200 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
361000 | usd |
CY2024 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-401228 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
213426 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
431374 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
217948 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
30146 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
431374 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
90813 | usd |
CY2024 | COPR |
Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
|
269085 | usd |
CY2023 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
685166 | usd |
CY2024 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_802_eus-gaap--NatureOfOperations_zd6ZkkYVFy03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_828_zjnDQabnAM3i">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased <span id="xdx_906_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20220203__20220203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_ztHQJi7A4G01" title="Buyer purchased common stock shares">16,644,820</span> shares of common stock of the Company from the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zjr5DMej45Fj" title="Number of shares issued">182,240,000</span> shares of the Company’s common stock, par value $<span id="xdx_904_eus-gaap--EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_c20230123__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zgqOLbnpDHWe" title="Common stock, par value">0.001</span> per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ICUMO Background</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of exploring its mineral rights interests in the United States and at the date of these consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
30146 | usd |
CY2024 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3712047 | usd |
CY2024 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84F_eus-gaap--UseOfEstimates_zpA1zwRdj6Ec" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z5iCIWBJpzZb">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q1 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2024Q1 | us-gaap |
Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
|
3135000 | usd |
CY2024Q1 | COPR |
Bond Liabilities Maturities In Year Two
BondLiabilitiesMaturitiesInYearTwo
|
1546000 | usd |
CY2024Q1 | COPR |
Bond Liabilities Maturities In Year Three
BondLiabilitiesMaturitiesInYearThree
|
500000 | usd |
CY2024Q1 | COPR |
Bond Liabilities Maturities In Year Five
BondLiabilitiesMaturitiesInYearFive
|
1089000 | usd |
CY2024Q1 | us-gaap |
Longterm Transition Bond Current And Noncurrent
LongtermTransitionBondCurrentAndNoncurrent
|
3135000 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
23 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
23 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
79585 | usd |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
214647732 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
214647732 | shares |
CY2024 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
22646000 | shares |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
11323000 | shares |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
0.125 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
|
2027-12-31 | |
CY2024 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1324731 | usd |
CY2023 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
0 | usd |
CY2024Q1 | us-gaap |
Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
|
757000 | usd |
CY2024Q1 | us-gaap |
Share Price
SharePrice
|
0.22 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
0.13 | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.1110 | pure |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
2.6518 | pure |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0388 | pure |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
|
The remaining vesting milestones required to be met are (1) obtaining an updated PEA, (2) an uplist of the Company’s common stock to a national exchange and (3) the successful raising of $5 million or more in new capital. Each of these milestones vest an additional 20% of the options upon being met and were estimated to have a 50% probability of being met as of January 31, 2024. Management reviews the estimate of meeting each probability as well as the related timing at each reporting period | |
CY2023Q3 | us-gaap |
Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
|
216000 | usd |
CY2023Q4 | us-gaap |
Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
|
216000 | usd |
CY2023Q4 | us-gaap |
Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
|
216000 | usd |
CY2024Q1 | us-gaap |
Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
|
216000 | usd |
CY2023Q3 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
CY2023Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
112867 | usd |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
112867 | usd |
CY2023Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
112867 | usd |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
112867 | usd |
CY2024Q1 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
751916 | usd |
CY2023Q1 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
397846 | usd |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2024 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.05 | pure |
CY2024 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-285980 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-321337 | usd |
CY2024 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-68090 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-76509 | usd |
CY2024 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
354070 | usd |
CY2023 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
397846 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
751916 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
397846 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
751916 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
397846 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
751916 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
397846 | usd |
CY2024Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
751916 | usd |
CY2023Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
397846 | usd |